Jump Financial, LLC Alpine Immune Sciences, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	BUY	$8.54 - $20.22 $475,848 - $1.13 Million	55,720 New	55,720 $1.06 Million
Q4 2023 Feb 07, 2024	BUY	$8.54 - $20.22 $475,848 - $1.13 Million	55,720 New	55,720 $1.06 Million
Q3 2022 Nov 07, 2022	BUY	$6.89 - $9.39 $68,989 - $94,022	10,013 New	10,013 $72,000
Q1 2022 May 12, 2022	SELL	$6.41 - $13.89 $80,766 - $175,014	-12,600 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$10.41 - $13.95 $131,166 - $175,770	12,600 New	12,600 $175,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.